Drug Trial Radar · NCT05556824
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
255
Actual
Start
Mar 3, 2023
Primary completion
May 27, 2026
Study completion May 27, 2026
Sponsor
- Lead sponsor
- Microbiome Health SciencesIndustry
- Sponsor type
- Industry
- Collaborators
- VBHRC Virginia Catalyst
- First posted
- Sep 27, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effect of MHS-1031 on heartburn-free days in subjects with GERD-related heartburn symptoms.
Conditions
- Gastroesophageal Reflux
Interventions
MHS-1031Drug
Study medication will be supplied as a syrup in individual sachets containing 1g (1.5 mL) of MHS-1031. Subjects will be randomized in 2:1 fashion to either study drug (2) or placebo (1)
PlaceboOther
Matching placebo is an oral solution formulated to have a degree of sweetness and acidity similar to the study medication and will be provided in equivalent sachets containing 1.5g (1.5 mL) of the oral placebo solution.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Heartburn-free days/weekTime frame: 4 and 8 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Elite Clinical Studies LLC
Phoenix, Arizona
Angel City Research
Los Angeles, California
Wr-Msra, Llc
Lake City, Florida
A Positive Clinical Research
Miami, Florida
Advanced Gastroenterology Associates LLC
Palm Harbor, Florida
Health Synergy Clinical Research
West Palm Beach, Florida
West Palm Quality Research (WPQR)
West Palm Beach, Florida
EmVenio-Georgia (EMGA)
Atlanta, Georgia
WR-Mount Vernon Clinical Research (MVCR)
Sandy Springs, Georgia
Gastroenterology Associates of Western Michigan PLC (WMCR)
Wyoming, Michigan
M3 Wake Research (CPOR)
Raleigh, North Carolina
Vanderbilt University Medical Center
Nashville, Tennessee
SMS Clinical Research (SMSR)
Mesquite, Texas
A and U Family Medicine (NCR)
Sugar Land, Texas
University of Virginia Health System
Charlottesville, Virginia
Charlottesville Medical Research Center
Charlottesville, Virginia
Digestive Disease and Liver Specialists
Norfolk, Virginia
GI Research Partners, LLC
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.